FGFR2 and cancer: On the other hand, some reports suggest that variation in FGFR2, TOX3, HCN1, and at 2q35 may be more strongly associated with estrogen receptor-positive cancers [9,16,25], but mammographic density has not been found to be differentially related to breast cancers by steroid receptor status [29].